Crystal MacKenzie

1.6k total citations
8 papers, 328 citations indexed

About

Crystal MacKenzie is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Crystal MacKenzie has authored 8 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Crystal MacKenzie's work include Advanced Breast Cancer Therapies (3 papers), Cancer-related Molecular Pathways (3 papers) and Fibroblast Growth Factor Research (2 papers). Crystal MacKenzie is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Cancer-related Molecular Pathways (3 papers) and Fibroblast Growth Factor Research (2 papers). Crystal MacKenzie collaborates with scholars based in United States, Japan and Spain. Crystal MacKenzie's co-authors include Judy Oestreicher, Michael Byrne, Ken Aoshima, Sergei Agoulnik, Yoshiya Oda, François P. Bernier, Pavan Kumar, Zoltán Dezső, Mamoru Yanagimachi and Víctor Moreno and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Crystal MacKenzie

8 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Crystal MacKenzie United States 4 235 207 70 34 15 8 328
Manuela Grebing Denmark 6 398 1.7× 346 1.7× 34 0.5× 33 1.0× 7 0.5× 6 469
Anllely Fernández Chile 8 214 0.9× 78 0.4× 78 1.1× 77 2.3× 21 1.4× 10 268
Zhigang Li China 9 209 0.9× 82 0.4× 39 0.6× 47 1.4× 14 0.9× 14 298
Shona Pfeiffer Ireland 9 223 0.9× 135 0.7× 20 0.3× 26 0.8× 14 0.9× 15 322
Yanxi Peng China 7 565 2.4× 256 1.2× 31 0.4× 13 0.4× 8 0.5× 10 633
Simon Schafferer Austria 6 236 1.0× 172 0.8× 12 0.2× 16 0.5× 23 1.5× 7 316
Santra Brenna Germany 8 215 0.9× 81 0.4× 25 0.4× 106 3.1× 26 1.7× 12 351
Hung Tae Kim South Korea 9 119 0.5× 59 0.3× 52 0.7× 26 0.8× 15 1.0× 16 237
McKenzie Shaw United States 4 176 0.7× 62 0.3× 52 0.7× 25 0.7× 5 0.3× 4 251

Countries citing papers authored by Crystal MacKenzie

Since Specialization
Citations

This map shows the geographic impact of Crystal MacKenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crystal MacKenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crystal MacKenzie more than expected).

Fields of papers citing papers by Crystal MacKenzie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crystal MacKenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crystal MacKenzie. The network helps show where Crystal MacKenzie may publish in the future.

Co-authorship network of co-authors of Crystal MacKenzie

This figure shows the co-authorship network connecting the top 25 collaborators of Crystal MacKenzie. A scholar is included among the top collaborators of Crystal MacKenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crystal MacKenzie. Crystal MacKenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mita, Monica, Alain C. Mita, Miguel A. Villalona‐Calero, et al.. (2024). Abstract PO4-18-07: A dose escalation and cohort expansion study of the CDK9 inhibitor KB-0742 in triple negative breast cancer and transcriptionally addicted relapsed or refractory solid tumors. Cancer Research. 84(9_Supplement). PO4–18. 1 indexed citations
2.
Villalona‐Calero, Miguel A., Monica Mita, Alain C. Mita, et al.. (2023). Abstract B159: A first-in-human study of CDK9 inhibitor KB-0742 demonstrates evidence of tolerability and clinical activity. Molecular Cancer Therapeutics. 22(12_Supplement). B159–B159. 4 indexed citations
3.
Saffran, Douglas C., Nathalie Rioux, Tom Chen, et al.. (2021). Abstract P228: Preclinical pharmacokinetics and pharmacodynamics of KB-0742, a selective, oral CDK9 inhibitor. Molecular Cancer Therapeutics. 20(12_Supplement). P228–P228. 5 indexed citations
4.
Kumar, Pavan, Kun Yu, Zhaojie Zhang, et al.. (2019). H3B-6527 clinical biomarker assay development and characterization of HCC patient samples.. Journal of Clinical Oncology. 37(15_suppl). 4121–4121. 1 indexed citations
5.
Mercadé, T. Macarulla, Víctor Moreno, Binu V. John, et al.. (2019). A phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC) patients (pts).. Journal of Clinical Oncology. 37(15_suppl). 4095–4095. 9 indexed citations
6.
7.
Kumar, Pavan, Zoltán Dezső, Crystal MacKenzie, et al.. (2013). Circulating miRNA Biomarkers for Alzheimer's Disease. PLoS ONE. 8(7). e69807–e69807. 306 indexed citations
8.
Kumar, Pavan, Zoltán Dezső, Crystal MacKenzie, et al.. (2013). P1–234: Circulating miRNA biomarkers for Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuela Grebing Breakdown of academic impact, for papers by Anllely Fernández Breakdown of academic impact, for papers by Zhigang Li Breakdown of academic impact, for papers by Shona Pfeiffer Breakdown of academic impact, for papers by Yanxi Peng Breakdown of academic impact, for papers by Simon Schafferer Breakdown of academic impact, for papers by Santra Brenna Breakdown of academic impact, for papers by Hung Tae Kim Breakdown of academic impact, for papers by McKenzie Shaw
Rankless by CCL
2026